Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-361 | THZ1 | 0.0001 | 0.8363 | -0.02358 |
| BT-20 | THZ1 | 0.0001 | 0.9189 | -0.00167 |
| BT-20 | THZ531 | 0.0001 | 1.0122 | 0.00328 |
| MDA-MB-361 | THZ531 | 0.0001 | 0.6957 | -0.00138 |
| MDA-MB-361 | THZ531 | 0.0001 | 0.9675 | -0.01395 |
| HCC1143 | Alvocidib | 0.0001 | 1.0322 | -0.00311 |
| MDA-MB-436 | Alvocidib | 0.0001 | 1.0499 | -0.01451 |
| MDA-MB-436 | Alvocidib | 0.0001 | 0.9447 | 0.03120 |
| MDA-MB-436 | Alvocidib | 0.0001 | 0.9045 | -0.02304 |
| HCC1143 | Alvocidib | 0.0001 | 1.0177 | -0.00582 |
| MDA-MB-436 | THZ1 | 0.0001 | 0.9367 | -0.01789 |
| MDA-MB-436 | THZ1 | 0.0001 | 0.8635 | 0.02106 |
| MDA-MB-436 | THZ1 | 0.0001 | 0.9852 | -0.00372 |
| MDA-MB-436 | THZ531 | 0.0001 | 1.1376 | 0.00087 |
| HCC1143 | THZ1 | 0.0001 | 0.9670 | -0.01064 |
| MDA-MB-436 | THZ531 | 0.0001 | 1.1791 | -0.01967 |
| HCC1806 | Alvocidib | 0.0001 | 1.0246 | -0.00231 |
| MDA-MB-436 | THZ531 | 0.0001 | 1.0958 | -0.02402 |
| MDA-MB-453 | Alvocidib | 0.0001 | 1.0717 | -0.00020 |
| MDA-MB-453 | Alvocidib | 0.0001 | 0.9374 | 0.01991 |
| MDA-MB-453 | Alvocidib | 0.0001 | 1.1675 | -0.00393 |
| HCC1143 | THZ1 | 0.0001 | 0.9634 | -0.00555 |
| HCC1143 | THZ1 | 0.0001 | 0.9646 | -0.00625 |
| HCC1954 | THZ531 | 0.0001 | 1.0140 | -0.00259 |
| HCC1954 | THZ1 | 0.0001 | 1.0685 | -0.00592 |